Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/21335
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2021-07-30T07:58:17Z | - |
dc.date.available | 2021-07-30T07:58:17Z | - |
dc.date.issued | 1999 | - |
dc.identifier.citation | Orhan, B. (1999). "Doxorubicin cardiotoxicity: Growing importance". Journal of Clinical Oncology, 17(7), 2294-2295. | en_US |
dc.identifier.issn | 0732-183X | - |
dc.identifier.uri | https://doi.org/10.1200/JCO.1999.17.7.2293c | - |
dc.identifier.uri | http://hdl.handle.net/11452/21335 | - |
dc.language.iso | en | en_US |
dc.publisher | W B Saunders Co | tr_TR |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Oncology | en_US |
dc.subject | Continuous intravenous-infusion | en_US |
dc.subject | Breast-cancer | en_US |
dc.subject | Reduced cardiotoxicity | en_US |
dc.subject | Therapy | en_US |
dc.subject | Schedule | en_US |
dc.title | Doxorubicin cardiotoxicity: Growing importance | en_US |
dc.type | Letter | en_US |
dc.identifier.wos | 000081264300047 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi. | tr_TR |
dc.identifier.startpage | 2294 | tr_TR |
dc.identifier.endpage | 2295 | tr_TR |
dc.identifier.volume | 17 | tr_TR |
dc.identifier.issue | 7 | tr_TR |
dc.relation.journal | Journal of Clinical Oncology | en_US |
dc.contributor.buuauthor | Orhan, Bülent | - |
dc.identifier.pubmed | 10561289 | tr_TR |
dc.subject.wos | Oncology | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.pubmed | Pubmed | en_US |
dc.wos.quartile | Q1 | en_US |
Appears in Collections: | Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.